Difference between revisions of "Team:TCU Taiwan/Modeling"

Line 45: Line 45:
 
<tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> About our modeling</font></span></h1></td></tr>
 
<tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> About our modeling</font></span></h1></td></tr>
 
<tr><td><h1><span style="font-family:Calibri;text-align:left;"><font size="5">
 
<tr><td><h1><span style="font-family:Calibri;text-align:left;"><font size="5">
To increase efficiency in isolating our AMPs, we introduced a signal peptide upstream of the N-terminal of mature antimicrobial peptides. This signal peptide is obtained from chitinase C of S.lividans (MGFRHKAAALAATLALPLAGLVGLASPAQA). When the premature peptides enter the periplasmic space, peptidase will identify the cleavage site Ala-Gln-Ala and cut at the double Ala between the signal and mature peptide. </br></br>
+
 
To ensure and verify this process, we have attached an Ala at the N-terminal of AMPs. When applying a protein secondary structure prediction software base on the known peptide structure, we can analyze whether the attached Ala may have an effect on the peptide folding process.
+
 
</br></br>
 
</br></br>
 
</font></span></h1></td>
 
</font></span></h1></td>
Line 57: Line 56:
 
  <div class="inner">
 
  <div class="inner">
 
<table width="95%"  align="center">
 
<table width="95%"  align="center">
<tr><td align="left"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> Signiferin peptide structure analysis</font></span></h1></td></tr>
+
<tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="6"><font-weight: 700;>Macro Dilution</font></span></h1></td></tr>
  <tr>
+
    <td width="90%" align="center"><img src="https://static.igem.org/mediawiki/2015/e/ee/2015tcutaiwanModelingwithoutA1.jpg" align=center width="80%"  title="Result 1"></td>
+
  </tr> 
+
 
</table>
 
</table>
 
</div>
 
</div>
 
</div>
 
</div>
 +
  
 
<div id="st1" class="st">
 
<div id="st1" class="st">
 
  <div class="inner">
 
  <div class="inner">
 
<table width="95%"  align="center">
 
<table width="95%"  align="center">
 
+
  <tr>
     <td width="45%" align="center"><img src="https://static.igem.org/mediawiki/2015/f/f8/2015tcutaiwanModelingwithA1.jpg" align=center width="80%"  title="Result 1"></td>
+
     <td width="90%" align="center"><img src="https://static.igem.org/mediawiki/2015/a/a7/2015tcutaiwanThe_peptides_efficiency_of_disinfection.JPG" align=center width="60%"  title="Result 1"></td>
 
   </tr>   
 
   </tr>   
</table>
+
<tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
</div>
+
</div>
+
  
<div id="st1" class="st">
 
<div class="inner">
 
<table width="95%"  align="center">
 
<tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
 
The first column shows the amino acid sequence that we predict.
 
The second column shows that AMPs corresponding secondary structure state are still a-helix.
 
The third column shows the probability of correct prediction.
 
 
</br></br>
 
</br></br>
</font></span></h1></td></tr>  
+
</font></span></h1></td></tr>
 
</table>
 
</table>
 
</div>
 
</div>
 
</div>
 
</div>
  
<div id="st1" class="st">
 
<div class="inner">
 
<table width="95%"  align="center">
 
  <tr>
 
<tr><td align="left"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> Epinicedin-1 pepetide structure analysis</font></span></h1></td></tr>
 
  <tr>
 
  <td width="45%" align="center"><img src="https://static.igem.org/mediawiki/2015/8/82/2015tcutaiwanModelingepi-1withoutA1.jpg" align=center width="80%"  title="Result 4"></td>
 
  </tr> 
 
</table>
 
</div>
 
</div>
 
  
 
<div id="st1" class="st">
 
<div id="st1" class="st">
 
  <div class="inner">
 
  <div class="inner">
 
<table width="95%"  align="center">
 
<table width="95%"  align="center">
  <tr>
+
<tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="6"><font-weight: 700;> Cell </font></span></h1></td></tr>
<td width="90%" align="center"><img src="https://static.igem.org/mediawiki/2015/1/10/2015tcutaiwanigemModelingepi-1withA1.jpg" align=center width="80%"  title="Result 3"></td>
+
   
+
  </tr>
+
 
</table>
 
</table>
 
</div>
 
</div>
 
</div>
 
</div>
  
<div id="st1" class="st">
 
<div class="inner">
 
<table width="95%"  align="center">
 
<tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
 
The first column shows the amino acid sequence that we predict.
 
The second column shows that AMPs corresponding secondary structure state are still a-helix.
 
The third column shows the probability of correct prediction.
 
</br></br>
 
</font></span></h1></td></tr>
 
</table>
 
</div>
 
</div>
 
  
  
<div id="st1" class="st">
 
<div class="inner">
 
<table width="95%"  align="center">
 
  
<tr><td align="center"><h1><span style="font-family:Arial Black;"><font size="7"><font-weight: 700;> Conclusion</font></span></h1></td></tr>
+
 
<tr><td><h1><span style="font-family:Calibri;text-align:justify;"><font size="5"></br>
+
Through the analysis of the peptide secondary structure and confirmation of the -helix structure, the results show whether Ala is attached to Signiferin or Epinecidin-1, the peptide did not affect the peptide folding process. process.
+
</br></br>
+
</font></span></h1></td></tr>
+
</table>
+
</div>
+
</div>
+
 
</body>   
 
</body>   
 
</html>
 
</html>
 
{{TCU_Taiwan/CSSfooter}}
 
{{TCU_Taiwan/CSSfooter}}

Revision as of 20:11, 18 September 2015

About our modeling



Macro Dilution




Cell



             
Flag Counter
Contact us
tcutaiwan@gmail.com
No.701, Sec. 3, Zhongyang Rd. Hualien 97004, Taiwan